Geron
GERN
#6742
Rank
S$1.00 B
Marketcap
S$1.57
Share price
0.41%
Change (1 day)
-12.96%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2026 (TTM): -S$48.15 Million

According to Geron's latest financial reports the company's current earnings are S$0.20 Billion. In 2025 the company made an earning of -S$65.1 Million, an increase over its 2024 earnings that were of -S$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$48.15 Million-26.04%
2025 -S$65.1 Million-67.42%
2024 -S$0.2 Billion-11.23%
2023 -S$0.23 Billion30.22%
2022 -S$0.18 Billion20.15%
2021 -S$0.15 Billion50.08%
2020 -S$95.88 Million4.46%
2019 -S$91.78 Million130.68%
2018 -S$39.79 Million8.84%
2017 -S$36.56 Million-3.08%
2016 -S$37.72 Million-22080.6%
2015 S$0.17 M-100.38%
2014 -S$45.57 Million-7.14%
2013 -S$49.07 Million
2011 -S$0.12 Billion19.04%
2010 -S$97.53 Million8.45%
2009 -S$89.93 Million-2.51%
2008 -S$92.25 Million14.65%
2007 -S$80.46 Million32.68%
2006 -S$60.64 Million25.59%
2005 -S$48.29 Million4.36%
2004 -S$46.27 Million19.73%
2003 -S$38.65 Million-15.46%
2002 -S$45.72 Million1.94%
2001 -S$44.84 Million33.59%
2000 -S$33.57 Million27.53%
1999 -S$26.32 Million63.13%
1998 -S$16.14 Million15.6%
1997 -S$13.96 Million-10.66%
1996 -S$15.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
-S$2.51 Billion 5,130.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
S$2.51 B-5,363.42%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-S$88.66 Million 85.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
S$0.32 B-769.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-S$21.16 Million-55.80%๐Ÿ‡บ๐Ÿ‡ธ USA